Zura Bio Ltd (94E)

Currency in EUR
5.0000
+0.1600(+3.31%)
Delayed Data·
94E is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.00005.0000
52 wk Range
1.61006.0000
Key Statistics
Bid/Ask
5.00 / 5.10
Prev. Close
4.84
Open
5
Day's Range
5-5
52 wk Range
1.61-6
Volume
-
Average Volume (3m)
151
1-Year Change
190.6977%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
94E Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Zura Bio Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy

Earnings

Latest Release
11-08-2026
EPS / Forecast
-0.21 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

94E Income Statement

Compare 94E to Peers and Sector

Metrics to compare
94E
Peers
Sector
Relationship
P/E Ratio
−4.8x−11.1x−0.4x
PEG Ratio
0.090.150.00
Price/Book
2.9x5.1x2.6x
Price / LTM Sales
-12.0x3.1x
Upside (Analyst Target)
-75.5%49.6%
Fair Value Upside
Unlock−8.0%7.1%Unlock

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.38M5.61%25.92M
Other Institutional Investors
107.94M94.39%520.25M
Public Companies & Retail Investors
0.000.00%0.00
Total
113.31M100.00%546.17M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Athanor Capital, LP12.09%1,15,81,40255,822
Montanova Capital, LLC9.85%94,43,00145,515

FAQ

What Is the Zura (94E) Share Price Today?

The Zura share price today is 5.0000.

What is the current Zura (94E) share price and day range?

As of 04-09-2026, the Zura share price is 5.0000, with a previous close of 4.8400. The share price has ranged from 5.0000 to 5.0000 today, while the 52-week range spans from 1.6100 to 6.0000.

What Is the Zura Market Cap?

As of today, Zura market cap is 484.5800M.

What Is Zura's Earnings Per Share (TTM)?

The Zura EPS (TTM) is -1.0870.

From a Technical Analysis Perspective, Is 94E a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

What Stock Exchange Does Zura Trade On?

Zura is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for Zura?

The stock symbol for Zura is "94E."

How Many Times Has Zura Stock Split?

Zura has split 0 times.

How Many Employees Does Zura Have?

Zura has 40 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.